A recent report showed that intestinal manifestations and IBD are prevalent in X-linked agammaglobulinemia (XLA) patients8 with loss-of-function mutations in Btk gene9, suggesting that Btk-deficiency is a genetic risk factor for IBD. The gene discussed is BTK; the disease is X-linked agammaglobulinemia.